David Szekeres
Overview
David Szekeres received an average of $2M in total compensation, including $452K in salary, at Heron Therapeutics from 2020 to 2023.
Source: SEC filings on April 29, 2024, May 1, 2023, April 25, 2022, and April 22, 2021.
Related executives
We found 22 more executives who work or worked at Heron Therapeutics.
Craig Collard
Heron Therapeutics
Chief Executive Officer
Barry Quart
Heron Therapeutics
Chief Executive Officer
Ira Duarte
Heron Therapeutics
Chief Financial Officer
William Forbes
Heron Therapeutics
Chief Development Officer
Kimberly Manhard
Heron Therapeutics
Executive Vice President, Drug Development
John Poyhonen
Heron Therapeutics
President and Chief Commercial Officer
Lisa Peraza
Heron Therapeutics
Chief Accounting Officer
Robert Hoffman
Heron Therapeutics
Chief Financial Officer
News
Heron Therapeutics CEO Craig Collard receives $11M in 2023
April 29, 2024
Heron Therapeutics Executive Vice President, Drug Development Kimberly Manhard's 2022 pay falls 22% to $1.4M
May 1, 2023
Heron Therapeutics CEO Barry Quart's 2021 pay rises 2% to $5.4M
April 25, 2022
Heron Therapeutics CEO Barry Quart's 2020 pay slips 9% to $5.3M
April 22, 2021